CONMED Corp — Director's Dealing 2018

Apr 30, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2018-04-27

Reporting Person: JONAS DANIEL (EVP Legal Affairs,Gen. Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-04-27	Common Stock	M	4680	$44.90	Acquired	23245	Direct
2018-04-27	Common Stock	F	3717	$65.25	Disposed	19528	Direct
2018-04-27	Common Stock	S	2000	$65.58	Disposed	17528	Direct
2018-04-27	Common Stock	G	100	—	Disposed	17428	Direct
2018-04-27	Common Stock	G	100	—	Acquired	100	Indirect
2018-04-27	Common Stock	G	100	—	Disposed	17328	Direct
2018-04-27	Common Stock	G	100	—	Acquired	100	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-04-27	Sars (Stock Appreciation Rights)	$44.90	M	4680	Disposed	2024-06-01	Common Stock (4680)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.575 to $65.589. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: This transaction is a gift of securities by the reporting person to his daughter, who shares the reporting person's household.

F3: This transaction is a gift of securities by the reporting person to his daughter, who shares the reporting person's household.

F4: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.